Compare ABEO & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEO | TSSI |
|---|---|---|
| Founded | 1974 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.5M | 273.7M |
| IPO Year | 2005 | 2005 |
| Metric | ABEO | TSSI |
|---|---|---|
| Price | $2.28 | $6.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $18.38 | $14.50 |
| AVG Volume (30 Days) | ★ 1.7M | 849.0K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | 133.33 |
| EPS | N/A | ★ 0.16 |
| Revenue | $2,998,000.00 | ★ $245,719,000.00 |
| Revenue This Year | $731.38 | N/A |
| Revenue Next Year | $129.85 | $8.51 |
| P/E Ratio | ★ N/A | $43.25 |
| Revenue Growth | ★ 258.18 | 65.86 |
| 52 Week Low | $2.30 | $5.90 |
| 52 Week High | $7.65 | $17.49 |
| Indicator | ABEO | TSSI |
|---|---|---|
| Relative Strength Index (RSI) | 17.41 | 41.65 |
| Support Level | N/A | N/A |
| Resistance Level | $5.77 | $7.79 |
| Average True Range (ATR) | 0.30 | 0.53 |
| MACD | -0.19 | 0.04 |
| Stochastic Oscillator | 2.26 | 46.03 |
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
TSS Inc provides a comprehensive suite of services for the integration of complex Artificial Intelligence (AI) technologies, planning, design, deployment, maintenance, and refresh of end-user and enterprise systems, including the mission-critical facilities that are housed. It provides a single-source solution for enabling technologies in data centers, operations centers, network facilities, server rooms, security operations centers, communications facilities, and the infrastructure systems that are critical to their functions. Services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services.